Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08SLU
|
|||
Drug Name |
US9453017, 1
|
|||
Synonyms |
CHEMBL3925090; BDBM247409; US9453017, 1
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H27FN4O2
|
|||
Canonical SMILES |
C1CN(CCC12CNC(=O)N2C3=CC(=CC=C3)F)CCNC(=O)C4=CC5=CC=CC=C5C=C4
|
|||
InChI |
1S/C26H27FN4O2/c27-22-6-3-7-23(17-22)31-25(33)29-18-26(31)10-13-30(14-11-26)15-12-28-24(32)21-9-8-19-4-1-2-5-20(19)16-21/h1-9,16-17H,10-15,18H2,(H,28,32)(H,29,33)
|
|||
InChIKey |
BYFCBILNFVVIKQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phospholipase D1 (PLD1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Phospholipase D1 (PLD1) | Target's Patent Info | [1] | |
BioCyc | Phospholipases | |||
KEGG Pathway | Glycerophospholipid metabolism | |||
Ether lipid metabolism | ||||
Metabolic pathways | ||||
Ras signaling pathway | ||||
cAMP signaling pathway | ||||
Sphingolipid signaling pathway | ||||
Endocytosis | ||||
Fc gamma R-mediated phagocytosis | ||||
Glutamatergic synapse | ||||
GnRH signaling pathway | ||||
Pathways in cancer | ||||
Pancreatic cancer | ||||
Choline metabolism in cancer | ||||
Panther Pathway | Angiogenesis | |||
Ras Pathway | ||||
Pathway Interaction Database | RhoA signaling pathway | |||
Arf6 trafficking events | ||||
CDC42 signaling events | ||||
Arf6 downstream pathway | ||||
mTOR signaling pathway | ||||
ErbB1 downstream signaling | ||||
IL8- and CXCR1-mediated signaling events | ||||
Alpha-synuclein signaling | ||||
Reactome | Role of phospholipids in phagocytosis | |||
WikiPathways | EGF/EGFR Signaling Pathway | |||
TSH signaling pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Antiviral therapies with phospholipase D inhibitors. US9453017. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.